Growth in the marine sector is welcome, but needs to be sensitively managed; we shouldn’t put wind turbines in fishing grounds. Investing in seabed mapping technology will ensure resources are used in a sustainable way, says Maria do Céu Patrão Neves, MEP

It’s a virtuous circle: New approval processes put in place by the European Medicines Agency are de-risking drug development, promoting investment in early-stage biotech and meeting unmet medical needs, says Paul Morton

The EU must take action to translate expertise in key underpinning technologies such as biotechnology, photonics and nanotechnology into industry-powered growth, says EU Commissioner Antonio Tajani

The Third Annual Worldview Bio-Innovation Scorecard report, published by Scientific American, points to progress in Europe

With a strong pipeline of drugs in development, a good flow of venture capital investment and seven IPOs, 2010 was an “exceptional” year, says France Biotech

Europe’s biggest-ever private financing round by a biotech doesn’t mean the capital drought is over, says Martin Edwards of Novo Ventures.